According to a recent LinkedIn post from Doccla, the company is associated with the Comfort Tracker service used by Sussex Community NHS Foundation Trust to support patients in the last 12 months of life at home. The post highlights that more than 150 people have reportedly used the service, with patient feedback including feelings of being “reassured” and “secure.”
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The post suggests Doccla’s remote care technology is being applied in end-of-life and community palliative care settings within the U.K. National Health Service. For investors, this could indicate growing traction in clinically sensitive, high-acuity use cases, potentially strengthening Doccla’s positioning in remote patient monitoring and supporting future contract or expansion opportunities with NHS and other health systems.